EOFlow Submits Application to the U.S. FDA for its Wearable Insulin Pump 'EOPatch'
- Written by PR Newswire
- Plans to finalize its U.S. distribution strategy in 2023
- Aims to enter the U.S., the world's largest diabetes market, with its current disposable wearable insulin pump 'EOPatch'
SAN JOSE, Calif. , Dec. 27, 2022 /PRNewswire/ -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery systems (DDS),...
